%0 Generic
%T Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma
%A Arnhold, Viktor
%A Schmelz, Karin
%A Proba, Jutta
%A Winkler, Annika
%A Wünschel, Jasmin
%A Toedling, Joern
%A Deubzer, Hedwig E.
%A Künkele, Annette
%A Eggert, Angelika
%A Schulte, Johannes H.
%A Hundsdoerfer, Patrick
%I Impact Journals, LLC
%@ 1949-2553
%K Oncology
%D 2018
%C Impact Journals, LLC
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation